Core Viewpoint - Option Care Health, Inc. reported solid financial results for the fourth quarter and full year 2024, demonstrating resilience in a challenging environment while focusing on patient-centered care [4]. Fourth Quarter 2024 Financial Highlights - Net revenue reached 1,346.4million,a19.71,124.4 million in Q4 2023 [6]. - Gross profit was 268.4million,representing19.9247.1 million (22.0% of net revenue) in Q4 2023 [6]. - Net income was 60.1million,comparedto57.2 million in Q4 2023, with diluted earnings per share of 0.35,a9.40.32 [6]. - Adjusted net income was 75.5million,upfrom66.7 million in Q4 2023, with adjusted diluted earnings per share of 0.44,a15.80.38 [6]. - Adjusted EBITDA was 121.6million,an8.9111.6 million in Q4 2023 [6]. - Cash flow from operations was 36.1million,down29.151.0 million in Q4 2023 [6]. - Approximately 90.0millionofstockwasrepurchasedinQ42024[6].FullYear2024FinancialHighlights−Totalnetrevenuefortheyearwas4,998.2 million, a 16.2% increase from 4,302.3millionin2023[6].−Grossprofitfortheyearwas1,013.0 million, or 20.3% of revenue, up 3.2% from 981.2million(22.8211.8 million, down from 267.1millionin2023,withdilutedearningspershareof1.23, a 16.9% decrease from 1.48[6].−Adjustednetincomewas272.8 million, compared to 257.7millionin2023,withadjusteddilutedearningspershareof1.58, a 10.5% increase from 1.43[6].−AdjustedEBITDAfortheyearwas443.8 million, up 4.4% from 425.2millionin2023[6].−Cashflowfromoperationstotaled323.4 million, down 12.9% from 371.3millionin2023[6].FullYear2025FinancialGuidance−Expectednetrevenueisprojectedtobebetween5.3 billion and 5.5billion[7].−Adjusteddilutedearningspershareisanticipatedtobebetween1.59 and 1.69[7].−AdjustedEBITDAisexpectedtorangefrom450 million to 470million[7].−Cashflowfromoperationsisprojectedtobeatleast320 million [7]. - Effective tax rate is estimated to be between 25% and 27% [7]. - Net interest expense is expected to be approximately 55millionto60 million [7]. Company Overview - Option Care Health is the largest independent provider of home and alternate site infusion services in the U.S., employing over 8,000 team members, including more than 5,000 clinicians [8].